Obese Patients Create New Transportation Opportunities
Nearly 40 million U.S. adults are classified as obese. Of these, it is estimated that four million are severely obese and 1.5 million are morbidly […]
cancer
Aethlon Seeks to Reinforce Hemopurifier’s Broad-Spectrum Utility with West Nile Studies
Aethlon Medical’s Hemopurifier has been shown to capture or inhibit the growth of other envelope viruses including HIV, SIV, FIV, Hepatitis C, Measles, Mumps, Influenza, […]
Delcath Presents Positive Phase II Data on PHP System in Treatment of Inoperable Liver Cancer
One of the central problems in using chemotherapy to treat cancer is its harmful effect on organ health. Lower dosages of the drug are often […]
[Video Profile] Interview with Craig Davenport, President & CEO of Endocare
Each year over 234,000 new cases of prostate cancer are diagnosed in the U.S. Treatment options include surgery, radiation therapy, hormone therapy, “watchful waiting” and […]
Painting the Colon: Early Stage Cancer Detection without Biopsy
Most cases of colon cancer begin as small noncancerous polyps. Over time these polyps may become colon cancers. Regular screening helps identify polyps before they […]
New Insurance Contracts for I-Flow’s ON-Q
I-Flow Corporation develops ambulatory drug delivery systems for pain management and infusion therapy. The company’s line of compact and portable infusion pumps includes catheters and […]
[Video Profile] Interview with Ron Andrews, President & CEO of Clarient
Clarient provides access to technologies and services for the characterization, assessment and treatment of cancer. The company offers a full range of diagnostic technologies and […]
Expanded Indications for Immunicon’s CellSearch
Immunicon’s CellSearch Circulating Tumor Cell (CTC) Kit has received FDA clearance as an aid in the monitoring of patients with metastatic prostate cancer. The kit […]
Aesculap to Distribute Misonix BoneScalpel
An example of the precision afforded by Misonix ultrasound cutting technologies: an eggshell is cut and the membrane is left intact. In an agreement finalized […]
HemeScan: CombiMatrix and Clarient to Advance Personalized Therapies for Chronic Lymphotic Leukemia
More partnering news, this time from CombiMatrix and Clarient, who will market and sell a genomics-based cancer test called HemeScan. HemeScan was developed by CombiMatrix; […]